Fred Volkmar is professor of child psychiatry, pediatrics and psychology at the Yale Child Study Center.
Fred Volkmar
Professor
Yale Child Study Center
From this contributor
Narrowing of ‘autism’ in DSM-5 runs counter to idea of broad spectrum
The strict definition of autism in the latest version of the diagnostic manual is antithetical to the idea that autism comes in a wide variety of forms.
Narrowing of ‘autism’ in DSM-5 runs counter to idea of broad spectrum
By
Brian Reichow, Fred Volkmar
9 May 2018 | 5 min read
Fred Volkmar: A decades-long perspective on autism research
Over the past 30 years, autism research pioneer Fred Volkmar says he has learned that researchers should be humble when assigning meaning to autism behavior, and seek to translate their findings into useful applications.
Fred Volkmar: A decades-long perspective on autism research
By
Fred Volkmar
8 November 2011 | 7 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read